Cite Filings / RNA
Feed Companies Filings Check
Sign in

CIK 0002093101

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Atrium Therapeutics, Inc.

Sign in to watch
Ticker
RNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
394639499
Phone
+1 619-876-0700
Business address
10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA
Filings Financials Insiders Search text
All 58 Financials 13 Executive Compensation 10 Insider Trading 30 Beneficial Ownership Interest 8 Business Combinations 10 Others 7
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-11-16
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-08-14
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-14
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-08-14
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-07-27
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-05-15
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-04-27
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-04-08

Page 1 of 1 · 8 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…